Experimentally, the LDL-C-lowering drug atorvastatin was demonstrated to inhibit the development of AAAs in a rat elastase-induced model, an effect attributed to its anti-inflammatory actions, including suppression of macrophage accumulation and associated reduced MMP-12 expression [52]. This evidence concerns the gene MMP12 and achalasia-alacrima syndrome.